scispace - formally typeset
I

Imke Mulder

Researcher at University of Aberdeen

Publications -  42
Citations -  3289

Imke Mulder is an academic researcher from University of Aberdeen. The author has contributed to research in topics: Gut flora & Immune system. The author has an hindex of 17, co-authored 41 publications receiving 2677 citations.

Papers
More filters
Journal ArticleDOI

The Key Role of Segmented Filamentous Bacteria in the Coordinated Maturation of Gut Helper T Cell Responses

TL;DR: Systematic analysis of gnotobiotic mice indicated that colonization by a whole mouse microbiota orchestrated a broad spectrum of proinflammatory T helper 1 (Th1), Th17, and regulatory T cell responses whereas most tested complex microbiota and individual bacteria failed to efficiently stimulate intestinal Tcell responses.
Journal ArticleDOI

Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging

TL;DR: Analysis of the 2,214,650-bp genome of Bifidobacterium bifidum PRL2010, a strain isolated from infant stool, revealed a nutrient-acquisition strategy that targets host-derived glycans, such as those present in mucin, which supports the notion that host- derived glycan catabolism is an important colonization factor for B. b ifidum with concomitant impact on intestinal microbiota ecology.
Journal ArticleDOI

Environmentally-acquired bacteria influence microbial diversity and natural innate immune responses at gut surfaces

TL;DR: It is observed that a microbiota dominated by lactobacilli may function to maintain mucosal immune homeostasis and limit pathogen colonization of the adult gut and mucosal innate immune function.
Journal ArticleDOI

Restricting Microbial Exposure in Early Life Negates the Immune Benefits Associated with Gut Colonization in Environments of High Microbial Diversity

TL;DR: The impact of limiting microbial exposure after initial colonization on the development of adult gut immunity is addressed and morphological maturation and gut closure were delayed in isolator-reared animals, although hard-wired events occurred later in development.
Journal ArticleDOI

Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid.

TL;DR: It is shown that single bacterial strains from the human gut microbiota have potential as novel HDI therapeutics for disease areas involving host epigenetic aberrations.